In a research report issued today, FBR analyst Vernon Bernardino reiterated an Outperform rating on shears of Novavax, Inc. (NASDAQ:NVAX), with a price target …
FBR analyst Vernon Bernardino was out today with a mix report on shares of Galena Biopharma Inc (NASDAQ:GALE), reiterating an Outperform rating while slashing the …
In a research report published on Thursday, FBR analyst Vernon Bernardino reiterated an Outperform rating on shares of Advaxis, Inc. (NASDAQ:ADXS) with a price …
FBR analyst Vernon Bernardino weighed in on Galena Biopharma Inc (NASDAQ:GALE), after the company announced that its Independent Data Monitoring Committee completed an interim analysis …
In a research report released today, MLV’s healthcare analyst Vernon Bernardino reiterated a Buy rating on shares of Pluristem Therapeutics Inc (NASDAQ:PSTI), with a $6 …
MLV analyst Vernon Bernardino reiterated a Buy rating on shares of Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) with a $1.
Analysts are weighing in today on Galena Biopharma Inc (NASDAQ:GALE) with mixed ratings, as the company released its second-quarter earnings results after the …
In a research report issued today, MLV analyst Vernon Bernardino reiterated a Hold rating on Intercept Pharmaceuticals Inc (NASDAQ:ICPT) with a price target of …
MLV’s healthcare analyst Vernon Bernardino came out with an optimistic view on Neostem Inc (NASDAQ:NBS), after the company announced the expansion of its existing contract manufacturing services agreement …
MLV analyst Vernon Bernardino came out today with a favorable report on Novavax, Inc. (NASDAQ:NVAX), as Fast Track designation was given by the FDA to MEDI-8897, a …
